EORTC-24954-HNCG-ROG

Phase III study on larynx preservation comparing induction chemotherapy and radiotherapy versus alternating chemo-radiotherapy in resectable hypopharynx and larynx cancers (Jointly with the EORTC Radiotherapy Cooperative Group)
Trial StatusFurther follow-up after final analysis of primary endpoint
DatesDate of activation: 23-Jul-96
Closed on : 15-May-04
Data management at EORTCFull
Phase3
Randomized trialYes
Type-
Targeted Sample size564
Number of steps1
Drug
Study StaffJean-Claude Horiot (Study Coordinator) - Clinique De Genolier, Genolier
Jean-Louis Lefebvre (Study Coordinator) - Centre Oscar Lambret, Lille
Livia Giurgea (Data Manager) - EORTC Headquarters, Brussels
Jessica Menis (Coordinating Physician) - EORTC Headquarters, Brussels
Leslie Herman (Project Manager) - EORTC Headquarters, Brussels, leslie.herman( at )eortc.be, +32 27741511
Type of cancerHead and Neck
Participating GroupsEORTC Head and Neck Cancer Group(Coordinating Group)
EORTC Radiation Oncology Group
Protocol summaryCancer.gov (PDQ)
ClinicalTrials.gov
NCT numberNCT00002839
EudraCT